Real-time enrollment status for this hereditary angioedema (hae) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 9:31 PM UTC
| NCT Number | NCT07298447 |
| Recruiting Status | Recruiting |
| Condition | Hereditary Angioedema (HAE) |
| Phase | PHASE3 |
| Target Enrollment | 20 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Ionis Pharmaceuticals, Inc. |
| Last Updated on CT.gov | August 5, 2026 (3 weeks ago) |
As of August 28, 2026: Clinical trial NCT07298447 is currently recruiting participants. This phase3 study for hereditary angioedema (hae) is actively seeking new participants at 7 locations across the United States. The study is sponsored by Ionis Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07298447 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07298447 was last updated 3 weeks ago (August 5, 2026). HelloStudys verifies this status automatically.